1. A randomized controlled trial of chronic vagus nerve
stimulation for treatment of medically intractable seizures. The
Vagus Nerve Stimulation Study Group. Neurology 45:224-30, 1995
2. Aicardi J, Chavrie JJ: Convulsive status epilepticus in
infants and children. A study of 239 cases. Epilepsia 11:187-197,
1970
3. Aird RB, Masland RL, Woodbury DM: The Epilepsies: A Critical
Review. New York, Raven Press, 1984
4. Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E:
Lorazepam versus diazepam in the acute treatment of epileptic
seizures and status epilepticus. Dev Med Child Neurol 37:682-8,
1995
5. Avoli M: Excitatory amino acid receptors in the human
epileptogenic neocortex. Epilepsy Res 10:33-40, 1991
6. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ,
Stefan H, Mirza W, Tarver WB, Wernicke JF: Vagus nerve stimulation
for treatment of partial seizures: 1. A controlled study of effect
on seizures. First International Vagus Nerve Stimulation Study
Group. Epilepsia 35:616-26, 1994
7. Carlson H, Ronneengstrom E, Ungerstedt U, et al.: Seizure
related elevations of extracellular amino acids in human focal
epilepsy. Neurosci Lett 140:30-2, 1992.
8. Cascino GD, Jack CR, Parisi JE etal: Magnetic resonance
imaging based on volume studies in temporal lobe
epilepsy:pathological correlations. Ann Neurol 30:31-36, 1991
9. Cascino GD: Epilepsy: contemporary perspectives on evaluation
and treatment. Mayo Clin Proc 69:1199-211, 1994
10. Chatrian GE, Bergamini L, Dondey M, Klass DW, Lennox-Buchtal
M, Petersen I: A glossary of terms not commonly used by clinical
electroencephalographers. Electroencepahl Clin Neurophysiol
37:538-548, 1974
11. Cheng JG, Xie XK: A study on opioid peptides in CSF of
patients with epilepsy. Epilepsy Res 6:141-145, 1990
12. Commission of Classification, International League Against
Epilepsy: Proposed provision of clinical and
electroencephalographical classification of epileptic seizures.
Epilepsia 22:489-501, 1981
13. Cooper JE: Epilepsy in a longitudinal survey of 5,000
children. Br Med J 1:1020-1022, 1965
14. Corsellis JAN, Bruton CJ: Neuropathology of status
epilepticus in humans. Adv Neurol 34:129-140, 1983
15. Dam AM: Epilepsy and neuron loss in the hippocampus.
Epilepsia 21:617-629, 1980
16. Dasheiff RM: Sudden unexpected death in epilepsy: a series
from an epilepsy surgery program and speculation on the
relationship to sudden cardiac death. J Clin Neurophysiol
8:216-222, 1991
17. Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ:
Management of status epilepticus. N Eng J Med 306:1337-1340, 1982
18. Dichter MA, Ayala GF: Cellular mechanisms of epilepsy: A
status report. Science 237:157-164, 1987
19. Dichter MA: Emerging insights into mechanisms of epilepsy:
Implications for new anetiepileptic drug development. Epilepsia
35(suppl. 4):S51-S57, 1994
20. Dingledine R, McBain CB, McNamara JO: Excitatory amino acids
in epilepsy. Trends Pharmacol Sci 11:334-8, 1990
21. Drug treatment of epilepsy. Drug Ther Bull 32:45-8,1994
22. Engel J Jr: Clincial neurophysiology, neuroimaging, and the
surgical treatment of epilepsy. Curr Opin Neurol Neurosurg 6:240-9,
1993
23. Engel J Jr: Seizures and Epilepsy. Philadelphia, F.A. Davis
Company, 1989
24. Engel J, Jr., Kuhl DE, Phelps ME: Patterns of human local
cerebral glucose metabolism during epileptic seizures. Science
218:64-66, 1982
25. Fisher RS, Pedley TA, Moody WJ, et al.: The role of
extracellular potassium in hippocampal epilepsy. Arch Neurol
33:76-83, 1976
26. Fowler M: Brain damage after febrile convulsions. Arch Dis
Childhood 32:67-76, 1957.
27. Frost JJ, Mayberg HS, Fisher RS, Douglass KH, Dannals RF,
Links JM, Wilson AA, Ravert HT, Rosenbaum AE, Snyder SH, et al:
Mu-opiate receptors measured by positron emission tomography are
increased in temporal lobe epilepsy. Ann Neurol 23:231-237, 1988.
28. Gale K: GABA and Epilepsy: Basic concepts from preclinical
research. Epilepsia 33(suppl. 5):S3-12, 1992
29. Gastaut H and International Panel of Experts: Dictionary of
Epilepsy. Part 1: Definitions. World Health Organization, Geneva,
1973
30. Gastaut H: Clinical and electroencephalographic
classification of epileptic seizures. Epilepsia 11:102-113, 1970
31. George R, Salinsky M, Kuzniecky R, Rosenfeld W, Bergen
D, Tarver WB, Wernicke JF: Vagus nerve stimulation for treatment of
partial seizures: 3. Long-term follow-up on first 67 patients
exiting a controlled study. First International Vagus Nerve
Stimulation Study Group. Epilepsia 35:637-43, 1994
32. Goddard GV: Development of epileptic seizures through brain
stimulation at low intensity. Nature 214:1020-1021, 1967
33. Hippocrates: The sacred disease, Medical Works of
Hippocrates. Edited by Chadwick J, Mann WN, Oxford, Blackwell,
1950, p. 189.
34. Hopkins A: Definitions and Epidemiology of Epilepsy. In
Hopkins A (ed), Epilepsy, Edited by Hopkins A, Chammon and Hall
Ltd., London, 1987, p1.
35. Jackson GD: New techniques in magnetic resonance and epilepsy.
Epilepsia 35(Suppl 6):S2-S13, 1994
36. Jantti V Eriksson K Hartikainen K Baer GA: Epileptic EEG
discharges during burst suppression. Neuropediatrics 25:271-273,
1994
37. Jeffreys JGR: Experimental neurobiology of epilepsies. Curr
Opin Neurol 7:113-22, 1994.
38. Johnson EW, De Lannerolle NC, Kim JH, et al.: "Central" and
"Peripheral" benzodiazepine receptors: Opposite changes in human
epileptogenic tissue. Neurology 42:811-15, 1992
39. Kalviainen R, Keranen T, Riekkinen PJ Sr: Place of newer
antiepileptic drugs in the treatment of epilepsy. Drugs
46:1009-24,1993
40. Kuisma M Roine RO: Propofol in prehospital treatment of
convulsive status epilepticus. Epilepsia 36:1241-3, 1995
41. Labar DR Ali A Root J: High-dose intravenous lorazepam for the
treatment of refractory status epilepticus. Neurology 44:1400-3,
1994
42. Lennox W, Lennox MA: Epilepsy and Related Disorders. Boston,
Little Brown, 1960
43. Levin R, Banks S, Berg B: Psychosocial dimensions of
epilepsy: a review of the literature. Epilepsia 29:805-16, 1988
44. Lombroso CT: Treatment of status epilepticus with diazepam.
Neurology 16:629-634, 1966
45. Loscher W: Basic aspects of epilepsy. Curr Opin Neurol
Neurosurg 6:223-32, 1993
46. Lux HD, Heinemann U, Dietzel I: Ionic changes and alterations
in the size of the extracellular space during epileptic activity.
Adv Neurol 44:619-39, 1986
47. Masukawa LM, Higashima M, Hart GJ, et al.: NMDA receptor
activation during epileptiform responses in the dentate gyrus of
epileptic patients. Brain Res 562:176-80, 1991
48. Mattson RH: Closed-circuit-televised videotape recording and
electroencephalography (CCTV/EEG) in convulsive status epilepticus.
Adv Neurol 34:37-46, 1983
49. Mattson RH: Current challenges in the treatment of epilepsy.
Neurology 44:S4-9, 1994
50. McDonald JW, Garofalo EA, Hood T, et al.: Altered excitatory
and inhibitory amino acid receptor binding in hippocampus of
patients with temporal lobe epilepsy. Ann Neurol 29:529-41, 1991
51. McMicken DB Freedland ES: Alcohol-related seizures.
Pathophysiology, differential diagnosis, evaluation, and treatment.
Emerg Med Clin North Am 12:1057-79,1994
52. McNamara JO: Cellular and molecular basis of epilepsy. J
Neurosci 14:3413-25, 1994.
53. McNamara JO: The neurobiological basis of epilepsy. Trends
Neurosci 15:357-9, 1992
54. Meldrum B: Physiological changes during prolonged seizures
and epileptic brain damage. Neuropediatrie 9:203-212, 1978
55. Meldrum BS, Horton RW: Physiology of status epilepticus in
primates. Arch Neurol 28:1-9, 1973
56. Minamato Y, Itano T, Tokuda M, et al.: In vivo microdialysis
of amino acid neurotransmitters in the hippocampus in amygdaloid
kindled rats. Brain Res 573:345-48, 1992
57. National Institutes of Health: Proceedings of the Consensus
Development Conference on Febrile Seizures. Epilepsia 22:377-381,
1981
58. Oxbury JM, Whitty CWM: Cause of consequences of status
epilepticus in adults. Brain 99:733-744, 1971
59. Parent JM Lowenstein DH: Treatment of refractory generalized
status epilepticus with continuous infusion of midazolam. Neurology
44:1837-40, 1994
60. Pedley TA: The pathophysiology of focal epilepsy:
Neurophysiological considerations. Ann Neurol 3:2-9, 1978
61. Penfield W: Epileptogenic lesions. Acta Neurol Psych Belg
56:75-88, 1956
62. Penfield W: , Jasper HH: Epilepsy and Functional Anatomy of
the Human Brain, Boston, Little Brown, 1954.
63. Pisani F, Perucca E, Avanzini G, Richens A(eds): New
Antiepileptic Drugs, Epilepsy Research suppl 3 1991
64. Ramabadran K, Bansinath M: Endogenous opioid peptides and
epilepsy. Int J Clin Pharmacol Ther Toxicol 28:47-62, 1986
65. Ramsay RE, Uthman BM, Augustinsson LE, Upton AR, Naritoku D,
Willis J, Treig T, Barolat G, Wernicke JF: Vagus nerve stimulation
for treatment of partial seizures: 2. Safety, side effects, and
tolerability. First International Vagus Nerve Stimulation Study
Group. Epilepsia 35:627-36,1994
66. Ramsay RE, Slater JD: Effects of antiepileptic drugs on
hormones. [Review]. Epilepsia. 32 Suppl 6:S60-7, 1991
67. Ronneengstrom E, Hillered L, Flink R, et al.: Intracerebral
microdialysis of extracellular amino acids in the human epileptic
focus. J Cereb Blood Flow Metab
68. Rose DF, Smith PD, Sato S: Magnetoencephalography and
epilepsy research. Science 238:329-35, 1987
69. Scholtes FB Renier WO Meinardi H: Generalized convulsive
status epilepticus: causes, therapy, and outcome in 346 patients.
Epilepsia 35:1104-12,1994
70. Schwartzkroin PA, Wyler AR: Mechanisms underlying
epileptiform burst discharge. Ann Neurol 7:95-107, 1980
71. Shorvon SD: Epidemiology, classification, natural history,
and genetics of epilepsy. Lancet 336:996, 1990
72. Siesjo BK, Wieloch T: Epileptic brain damage: Pathophysiology
and neurochemical pathology. Adv Neurol 144:813-847, 1986
73. Sperling MR: Hypoglycemic activation of focal abnormalities
in the EEG of patients considered for temporal lobectomy.
Electroencephalogr Clin Neurophysiol 58:506-512, 1984
74. Sutherland JM, Eadie MJ: The Epilepsies. London, Churchill
Livingstone, 1980.
75. Sutula T, Cascino G, Cavazos J, et al.: Mossy fiber synaptic
reorganization in the epileptic human temporal lobe. Ann Neurol
26:321-30, 1989
76. Swanson TH: The pathophysiology of human mesial temporal lobe
epilepsy. J Clin Neurophysiol 12:2-22,1995
77. Thurston TH, Thuston DI, O'Leary J: Prognosis in childhood
epilepsy. Follow-up study of 148 cases in which therapy had been
suspended after prolonged anticonvulsant control. N Eng J Med
286:169-174, 1972.
78. Tortella FC: Endogenous opioid peptides and epilepsy:
quieting the seizing brain? Trends Pharrmacol Sci 9:366-372, 1988
79. Treatment of convulsive status epilepticus. Recommendations of
the Epilepsy foundation of America's Working Group on Status
Epilepticus. JAMA 1993;270:854-9, 1993
80. Treiman DM: The role of benzodiazepines in the management of
status epilepticus. Neurology 40:342, 1990
81. van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi
H: Immunoglobulin treatment in epilepsy, a review of the
literature. Epilepsy Res 19:181-90,1994
82. van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W,
Wieser HG:Treatment of refractory epilepsy with intravenous
immunoglobulins. Results of the first double-blind/dose finding
clinical study. Int J Clin Lab Res 24:162-6,1994
83. Walker AE, Eruculei F: Post-traumatic epilepsy 15 years
later. Epilepsia 11:17-26, 1970
84. Walker MC, Smith SJ, Shorvon SD: The intensive care treatment
of convulsive status epilepticus in the UK. Results of a national
survey and recommendations. Anaesthesia 50:130-5,1995
85. Wannamaker BB: Autonomic nervous system and epilepsy.
Epilepsia 26 (Suppl):S3-S39, 1985.
86. Wasterlain CG: Mortality and morbidity from seizures.
Epilepsia 15:155-176, 1974
87. Wilder BJ: The treatment of epilepsy: An overview ofclinical
practices. Neurology 45(suppl 2)S7-S11, 1995.